Détails sur le projet
Description
Project Summary
Osteoarthritis (OA) is a debilitating degenerative disease that afflicts an estimated 27 million Americans age 25
and older. This disease leads to the progressive degradation of the articular layers of diarthrodial joints,
significantly compromising the main function of cartilage as a load bearing material, leading to pain and limiting
activities of daily living. To this day, there are very limited treatment options for slowing down the progression
of OA in its early stages. Most therapies, such as highly invasive partial and total joint replacement surgeries
are performed at the late stage of the disease. Introducing treatment options to earlier stages of OA presents
the potential to retard or slow down disease progression and thus significantly improve patient outcomes. The
primary function of articular cartilage is to transmit loads across the joint surfaces while simultaneously
minimizing friction and wear. This application describes the development of an ultrafast laser-based treatment
tool which has the ability to induce crosslinks into the cartilage collagen network without the addition of a
chemical agent, while simultaneously avoiding damaging effects of optical breakdown and ablation. Preliminary
data show that laser-induced crosslinks increase compressive stiffness and wear resistance, without
compromising cell viability, which may be expected to slow down progression of OA. The overall aim of this
application is to develop a range of effective and safe laser operating parameters that enhance cartilage
mechanical properties and wear resistance, enabling us to produce a clinically relevant protocol. We also aim
to assess the influence of laser-induced short-lived bursts of reactive oxygen species onto the long-term
response of cartilage during in vitro and in vivo culture. To translate this technology to future animal and
human studies, we will develop and test a laser-based clinical tool for arthroscopic treatment of cartilage in
situ. In specific aim 1, we will optimize a framework for structural, morphological and functional modification of
the cartilage extracellular matrix subject to femtosecond laser irradiation, using devitalized bovine and human
OA cartilage explants. In specific aim 2, we will narrow this range of operating parameters by testing short-term
and long-term viability of laser-treated live bovine and human OA (male & female) cartilage explants against
untreated controls, using in vitro culture up to 4 weeks. In specific aim 3, we will verify that laser-treated live
human OA cartilage explants exhibit comparable viability and health as untreated controls when implanted for
up to 8 weeks in the back of nude mice. We will also fabricate a fiber optic-based laser system and validate its
effectiveness in simulated in situ arthroscopic applications in OA knee joints. Upon completion of these
studies, we will have established effective and safe operating parameters for this novel laser treatment
modality, and created a practical tool to test this methodology in situ, first in large animals, then in humans.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 1/10/19 → 12/31/22 |
Financement
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: 84 060,00 $ US
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: 251 970,00 $ US
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: 250 747,00 $ US
Keywords
- Reumatología
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.